These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9721909)

  • 1. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.
    Alexi T; Hughes PE; Faull RL; Williams CE
    Neuroreport; 1998 Aug; 9(11):R57-64. PubMed ID: 9721909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Nitropropionic acid animal model and Huntington's disease.
    Borlongan CV; Koutouzis TK; Sanberg PR
    Neurosci Biobehav Rev; 1997 May; 21(3):289-93. PubMed ID: 9168265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A; Shetty S; Shirole T; Jagtap AG
    Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
    Thangarajan S; Ramachandran S; Krishnamurthy P
    Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation.
    Borlongan CV; Nishino H; Sanberg PR
    Neurosci Res; 1997 Jul; 28(3):185-9. PubMed ID: 9237266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
    Hanna DM; Tadros MG; Khalifa AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():36-51. PubMed ID: 25689821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.
    Upadhayay S; Yedke NG; Rahi V; Singh S; Kumar S; Arora A; Chandolia P; Kaur P; Kumar M; Koshal P; Jamwal S; Kumar P
    Neurochem Res; 2023 Jun; 48(6):1631-1647. PubMed ID: 36738367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats.
    Mahdy HM; Tadros MG; Mohamed MR; Karim AM; Khalifa AE
    Neurochem Int; 2011 Nov; 59(6):770-8. PubMed ID: 21827809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
    Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P
    J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous blockade of NMDA receptors and PARP-1 activity synergistically alleviate immunoexcitotoxicity and bioenergetics in 3-nitropropionic acid intoxicated mice: Evidences from memantine and 3-aminobenzamide interventions.
    Chidambaram SB; Vijayan R; Sekar S; Mani S; Rajamani B; Ganapathy R
    Eur J Pharmacol; 2017 May; 803():148-158. PubMed ID: 28322842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
    Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M
    Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM; Hilt DC
    Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
    Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.
    Sidhu A; Diwan V; Kaur H; Bhateja D; Singh CK; Sharma S; Padi SSV
    Metab Brain Dis; 2018 Dec; 33(6):1911-1921. PubMed ID: 30054774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.
    Kumar P; Kalonia H; Kumar A
    Life Sci; 2009 Nov; 85(19-20):711-8. PubMed ID: 19822156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
    Nakao N; Brundin P
    Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.